Federal Register / Vol. 60, No. 103 / Tuesday, May 30, 1995 / Notices 28157

assistance may be obtained from Drs.

Michael Colligan and Ray Sinclair (at

the same address), telephone (513) 533–

8225.

Please refer to Announcement 555

when requesting information and

submitting an application.

Potential applicants may obtain a

copy of Healthy People 2000 (Full

Report, Stock No. 017–001–00474–0) or

Healthy People 2000 (Summary Report,

Stock No. 017–001–00473–1) referenced

in the Introduction Section through the

Superintendent of Documents,

Government Printing Office,

Washington, DC 20402–9325, telephone

(202) 512–1800.

A copy of Participatory Ergonomics

Interventions in Meatpacking Plants,

(DHHS/NIOSH) Publication No. 94–124,

referenced in the Purpose Section, can

be obtained from the Publication

Dissemination office of CDC/NIOSH,

Cincinnati, OH 45226, telephone (513)

533–8573.

Dated: May 23, 1995.

Diane D. Porter,

Acting Director, National Institute for

Occupational Safety and Health, Centers for

Disease Control and Prevention (CDC).

[FR Doc. 95–13110 Filed 5–26–95; 8:45 am]

BILLING CODE 4163–19–P

[Announcement 556]

Work Organization Interventions to

Prevent Work-Related Musculoskeletal

Disorders in Office and Video Display

Terminal Work

Introduction

The Centers for Disease Control and

Prevention (CDC) announces the

availability of fiscal year (FY) 1995

funds for a cooperative agreement

program to develop work organization

interventions to prevent

musculoskeletal disorders in office and

video display terminal (VDT) workers.

The Public Health Service (PHS) is

committed to achieving the health

promotion and disease prevention

objectives of Healthy People 2000, a

PHS-led national activity to reduce

morbidity and mortality and improve

the quality of life. This announcement

is related to the priority area of

Occupational Safety and Health. (For

ordering a copy of Healthy People 2000,

see the Section Where to Obtain

Additional Information.)

Authority

This program is authorized under

sections 20 (a) and 22(e)(7) of the

Occupational Safety and Health Act (29

U.S.C. 669(a) and 671(e)(7)).

Smoke-Free Workplace

The Public Health Service strongly

encourages all grant recipients to

provide a smoke-free workplace and

promote the nonuse of all tobacco

products, and Pub. L. 103–227, the ProChildren Act of 1994, prohibits smoking

in certain facilities that receive Federal

funds in which education, library, day

care, health care, and early childhood

development services are provided to

children.

Eligible Applicants

Applications may be submitted by

public and private, non-profit and forprofit organizations and governments,

and their agencies. Thus, universities,

colleges, research institutions, hospitals,

other public and private organizations,

State and local health departments or

their bona fide agents, federally

recognized Indian tribal governments,

Indian tribes or Indian tribal

organizations, and small, minority-,

and/or women-owned businesses are

eligible to apply.

Availability of Funds

Approximately $140,000 is available

in FY 1995 to fund one award. It is

expected that the award will begin on or

about September 30, 1995, and will be

made for a 12-month budget period

within a project period of one to two

years. Funding estimates may vary and

are subject to change. Continuation

awards within the project period will be

made on the basis of satisfactory

progress and the availability of funds.

Purpose

The purpose of this cooperative

agreement is to utilize the special

resources of the extramural research

community to conduct studies, in

cooperation with CDC/NIOSH, to

demonstrate the effectiveness of work

organization interventions in reducing

work- related musculoskeletal disorders

(WRMD), and in improving

productivity, among VDT workers. The

funded project will focus on worksite

primary prevention efforts, replicating

and extending the CDC/NIOSH

interventions. This could include: (a)

Replication/validation of CDC/NIOSH

findings on work-rest schedules and

task rotation, (b) extension of these

interventions to other types of VDT and

office tasks, and (c) examination of other

types of work organization

interventions.

Prior studies have indicated that some

types of VDT jobs may pose higher risk

for stress and WRMDs, particularly jobs

involving highly repetitive and narrow

tasks (e.g., data entry or teleoperator

tasks). Such jobs are of particular

interest for this project. Both physical

and psychological symptoms will be

evaluated. Project results, in

combination with NIOSH findings, will

provide the basis for recommendations

regarding effective work organization

strategies for reducing WRMDs, and

improving performance in repetitive

VDT work. Project results will also

improve our understanding of

mechanisms mediating between work

organization variables and

musculoskeletal disorders in VDT work.

Program Requirements

In conducting activities to achieve the

purpose of this program, the recipient

will be responsible for the activities

under A.(Recipient Activities) and CDC/

NIOSH will be responsible for activities

under B.(CDC/NIOSH Activities).

A. Recipient Activities

1. Identify suitable study site(s); i.e.,

with large, stable populations of

workers performing repetitive VDT

work. Secure cooperation of

management and labor representatives

at the site(s) to participate in an

intervention study.

2. Develop a study protocol that

reviews the pertinent literature on VDTrelated musculoskeletal disorders and

work organization, describes the study

methodology, the data to be collected,

and the proposed analysis of the data.

Present the protocol to a panel of peer

reviewers and revise the protocol as

required for final approval.

3. Prepare necessary documentation

for reviews and/or clearances required

by PHS/CDC/NIOSH.

4. Perform data collection and

management. Data is to include

measures of worker symptomatology

and performance and can additionally

include records data on factors such as

absenteeism, health care utilization, etc.

Symptomatology can include

musculoskeletal discomfort, upper

extremity musculoskeletal disorders,

and indicators of negative mental health

(e.g., depression, anxiety, tension).

Performance indicators can include

measures such as keystrokes/hour,

forms/hour, and errors.

5. Prepare a final report summarizing

the study methodology, results

obtained, and conclusions reached.

Develop recommendations regarding

effective work organization

interventions to reduce stress, fatigue,

and WRMDs among VDT workers.

6. Report study results to the

scientific community via presentations

at professional conferences and articles

in peer-reviewed journals.
28158 Federal Register / Vol. 60, No. 103 / Tuesday, May 30, 1995 / Notices

B. CDC/NIOSH Activities

1. Provide scientific, epidemiologic,

work organization, ergonomic, and

medical collaboration for the successful

completion of this project.

2. Identify reviews and/or clearances

that must be fulfilled by the recipient,

and identify and convene a Peer Review

Panel to review draft study protocol.

3. Provide assistance in all stages of

the study including study design,

survey instrument design, the

collection, tabulation, and analysis of

data, interpretation of the results and

preparation of the written reports.

4. Provide instrumentation and

resources to investigate physiological

mechanisms in VDT WRMDs.

Evaluation Criteria

The application will be reviewed and

evaluated according to the following

criteria:

1. Understanding of the Problem (25%)

Responsiveness to the objective of the

cooperative agreement including: (a)

Applicant’s understanding of the

general objectives of the proposed

cooperative agreement, and (b) evidence

of ability to understand the problem and

to conceive/design effective

interventions.

2. Program Personnel (30%)

(a) Applicant’s technical experience

(e.g., in the areas of work organization,

WRMDs and office and VDT

ergonomics); (b) the qualifications (e.g.,

in the areas of industrial engineering,

psychology and occupational safety and

health) and time allocation of the

professional staff to be assigned to this

project, and (c) the applicant’s ability to

describe the approach to be used in

carrying out the responsibilities of the

applicant in this project.

3. Study Design (20%)

Steps proposed in planning and

implementing this project and the

respective responsibilities of the

applicant for carrying out those steps.

Also, the adequacy of the applicant’s

evidence of access to study populations.

4. Project Planning (15%)

The applicant’s schedule proposed for

accomplishing the activities to be

carried out in this project and for

evaluating the accomplishments.

5. Facilities and Resources (10%)

The adequacy of the applicant’s

facilities, equipment, and other

resources available for performance of

this project.

6. Budget Justification (not scored)

The budget will be evaluated to the

extent that it is reasonable, clearly

justified, and consistent with the

intended use of funds.

Executive Order 12372 Review

This program is not subject to the

Executive Order 12372 review.

Public Health System Reporting

Requirements

This program is not subject to the

Public Health System Reporting

Requirements.

Catalog of Federal Domestic Assistance

Number

The Catalog of Federal Domestic

Assistance number for this project is 93.283.

Other Requirements

Paperwork Reduction Act

Projects that involve the collection of

information from ten or more

individuals and funded by this

cooperative agreement will be subject to

review and approval by the Office of

Management and Budget (OMB) under

the Paperwork Reduction Act.

Human Subjects

If the proposed project involves

research on human subjects, the

applicant must comply with the

Department of Health and Human

Services Regulations, 45 CFR part 46,

regarding the protection of human

subjects. Assurance must be provided to

demonstrate the project will be subject

to initial and continuing review by an

appropriate institutional review

committee. The applicant will be

responsible for providing assurance in

accordance with the appropriate

guidelines and form provided in the

application kit.

In addition to other applicable

committees, Indian Health Service (IHS)

institutional review committees also

must review the project if any

component of IHS will be involved or

will support the research. If any

American Indian community is

involved, its tribal government must

also approve that portion of the project

applicable to it.

Application Submission and Deadline

The original and two copies of the

application PHS Form 5161–1 (Revised

7/92, OMB Number 0937–0189) must be

submitted to Henry S. Cassell, III, Grants

Management Officer, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), Mailstop

E–13, 255 East Paces Ferry Road, NE.,

Room 300, Atlanta, GA 30305, on or

before June 30, 1995.

1. Deadline: Applications will be

considered as meeting the deadline if

they are either:

(a) Received on or before the deadline

date, or

(b) Sent on or before the deadline date

and received in time for submission to

the objective review group. (The

applicants must request a legibly dated

U.S. Postal Service postmark or obtain

a legibly dated receipt from a

commercial carrier or the U.S. Postal

Service. Private metered postmarks will

not be acceptable as proof of timely

mailing.)

2. Late Applicants: Applications that

do not meet the criteria in 1.(a) or 1.(b)

above are considered late applications.

Late applications will not be considered

in the current competition and will be

returned to the applicants.

Where To Obtain Additional

Information

A complete program description and

information on application procedures

are contained in the application

package. Business management

technical assistance may be obtained

from Oppie Byrd, Grants Management

Specialist, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), 255 East Paces Ferry Road, NE.,

Room 300, Mailstop E–13, Atlanta, GA

30305, telephone (404) 842–6546.

Programmatic technical assistance

may be obtained from Naomi G.

Swanson, Ph.D., Chief, Motivation and

Stress Research Section, Applied

Psychology and Ergonomics Branch,

Division of Biomedical and Behavioral

Science, National Institute for

Occupational Safety and Health, Centers

for Disease Control and Prevention

(CDC), Mailstop C–24, 4676 Columbia

Parkway, Cincinnati, OH 45226–1998,

telephone (513) 533–8291, FAX (513)

533–8510.

Please refer to Announcement 556

when requesting information and

submitting an application.

Potential applicants may obtain a

copy of Healthy People 2000 (Full

Report, Stock No. 017–001–00474–0) or

Healthy People 2000 (Summary Report,

Stock No. 017–001–00473–1) referenced

in the Introduction Section through the

Superintendent of Documents,

Government Printing Office,

Washington, DC 20402–9325, telephone

(202) 512–1800.
Federal Register / Vol. 60, No. 103 / Tuesday, May 30, 1995 / Notices 28159

Dated: May 23, 1995.

Diane D. Porter,

Acting Director, National Institute for

Occupational Safety and Health, Centers for

Disease Control and Prevention (CDC).

[FR Doc. 95–13109 Filed 5–26–95; 8:45 am]

BILLING CODE 4163–19–P

Advisory Committee to the Director,

Centers for Disease Control and

Prevention; Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following committee

meeting.

Name: Advisory Committee to the Director,

CDC.

Time and Date: 8:30 a.m.–3 p.m., June 23,

1995.

Place: CDC, Auditorium A, 1600 Clifton

Road, NE, Atlanta, Georgia 30333.

Status: Open to the public, limited only by

the space available.

Purpose: This committee advises the

Director, CDC, on policy issues and broad

strategies that will enable CDC, the Nation’s

prevention agency, to fulfill its mission of

promoting health and quality of life by

preventing and controlling disease, injury,

and disability. The committee recommends

ways to incorporate prevention activities

more fully into health care. It also provides

guidance to help CDC work more effectively

with its various constituents, in both the

private and public sectors, to make

prevention a practical reality.

Matters To Be Discussed: The agenda will

include updates from CDC Director, David

Satcher, M.D., Ph.D., followed by committee

discussion on CDC’s evolving relationship

with managed care and major challenges to

public health science and to CDC programs.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information:

Martha F. Katz, Executive Secretary,

Advisory Committee to the Director, CDC,

1600 Clifton Road, NE, Mailstop D–23,

Atlanta, Georgia 30333, telephone 404/639–

3243.

Dated: May 23, 1995.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 95–13122 Filed 5–26–95; 8:45 am]

BILLING CODE 4163–18–M

Advisory Committee for Injury

Prevention and Control: Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC),

announces the following committee

meeting.

Name: Advisory Committee for Injury

Prevention and Control (ACIPC).

Times and Dates: 1 p.m.–4 p.m., July 10,

1995; 8:30 a.m.–3:15 p.m., July 11, 1995.

Place: Atlanta Airport Hilton and Towers,

1031 Virginia Avenue, Atlanta, Georgia

30354.

Status: Closed 1 p.m.–4 p.m., July 10, and

8:30 a.m.–9 a.m., July 11; Open 9 a.m.–3:15

p.m., July 11.

Purpose: The committee will continue to

make recommendations on policy, strategy,

objectives, and priorities including the

balance and mix of intramural and

extramural research; advise on the

implementation of a national plan for injury

prevention and control, the development of

new technologies and their application; and

review progress toward injury prevention

and control.

Matters to be Discussed

The meeting will convene in closed session

from 1 p.m. to 4 p.m. on July 10, 1995. The

purpose of this closed session is for the

Science and Program Review Work Group to

consider injury control research grant

applications recommended for further

consideration by CDC’s Injury Research Grant

Review Committee. On July 11, 1995, from

8:30 a.m. to 9 a.m., the meeting will convene

in closed session in order for the full

committee to vote on a funding

recommendation. These portions of the

meeting will be closed to the public in

accordance with provisions set forth in

section 552b(c) (4) and (6) title 5 U.S.C., and

the Determination of the Associate Director

for Management and Operations, CDC,

pursuant Pub. L. 92–463. Following the

closed sessions, the committee will discuss

(1) an update from the Director, National

Center for Injury Prevention and Control

(NCIPC), (2) updates on injury issues form

other Federal agencies, (3) overview of the

Consumer Product Safety Commission, (4)

issues in traumatic brain injury, and (5) a

report from the ad hoc work group.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information: Mr.

Tom Bartenfeld, Acting Executive Secretary,

ACIPC, NCIPC, Mailstop K–60, CDC, 4770

Buford Highway, NE, Atlanta, Georgia

30341–3724, telephone 404/488–4690.

Dated: May 23, 1995.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 95–13170 Filed 5–26–95; 8:45 am]

BILLING CODE 4163–18–M

Savannah River Site Environmental

Dose Reconstruction Project: Public

Meetings

The National Center for

Environmental Health (NCEH) of the

Centers for Disease Control and

Prevention (CDC), the Agency for Toxic

Substances and Disease Registry

(ATSDR), and the Radiological

Assessments Corporation announce the

following meetings.

Name: Savannah River Site Environmental

Dose Reconstruction Project.

Date: Tuesday, June 27, 1995—Wednesday,

June 28, 1995

Time: 7 p.m.–9 p.m.—7 p.m.–9 p.m.

Place: Holiday Inn Coliseum at the

University of South Carolina, 630

Assembly Street, Columbia, South Carolina

29201—Radisson Riverfront Augusta Hotel,

Two Tenth Street, Augusta, Georgia 30901.

Date: Thursday, June 29, 1995

Time: 7 p.m.–9 p.m.

Place: Savannah DeSoto Hilton, 15 East

Liberty Street, Savannah, Georgia 31401

Status: Open to the public for observation

and comment, limited only by the space

available. Seating space for 50 individuals

will be available at each meeting.

Background: Under a Memorandum of

Understanding (MOU) signed in December

1990 with the Department of Energy (DOE),

the Department of Health and Human

Services (HHS) has been given the

responsibility and resources for conducting

analytic epidemiologic investigations of

residents of communities in the vicinity of

DOE facilities and other persons potentially

exposed to radiation or to potential hazards

from non-nuclear energy production use.

HHS delegated program responsibility to

CDC.

In addition, an MOU was signed in October

1990 and renewed in November 1992

between ATSDR and DOE. The MOU

delineates the responsibilities and

procedures for ATSDR’s public health

activities at DOE sites required under

sections 104, 105, 107, and 120 of the

Comprehensive Environmental Response,

Compensation, and Liability Act (CERCLA or

‘‘Superfund’’). These activities include health

consultations and public health assessments

at DOE sites listed on, or proposed for, the

Superfund National Priorities List and at

sites that are the subject of petitions from the

public; and other health-related activities

such as epidemiologic studies, health

surveillance, exposure and disease registries,

health education, substance-specific applied

research, emergency response, and

preparation of toxicological profiles.

Community involvement is a critical part

of the HHS energy-related research and

activities. With an environmental dose

reconstruction for DOE’s Savannah River Site

(SRS) near Augusta, Georgia, as well as a

worker study at the same site, the availability

of a formal site-specific advisory committee

composed of citizens of the communities

surrounding the DOE sites is necessary to

provide consensus advice regarding these

projects. On December 1, 1994, the ‘‘Citizens

Advisory Committee on Public Health

Service Activities and Research at DOE

Sites’’ was chartered. This charter is in

response to the requests by representatives of

the communities surrounding DOE sites to

provide consensus advice and

recommendations on community concerns

related to CDC’s and ATSDR’s activities

related to the sites. Committee members will

be representatives of the concerned and

affected community, Native American Tribes,